Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer

Summary Objective: To evaluate the relation between serum total testosterone (TT) and prostate cancer (PCa) grade and the effect of race and demographic characteristics on such association. Method: We analyzed 695 patients undergoing radical prostatectomy (RP), of whom 423 had serum TT collected. Patients were classified as having hypogonadism or eugonadism based on two thresholds of testosterone: threshold 1 (300 ng/dL) and threshold 2 (250 ng/dL). We evaluated the relation between TT levels and a Gleason score (GS) ≥ 7 in RP specimens. Outcomes were evaluated using univariate and multivariate analyses, accounting for race and other demographic predictors. Results: Out of 423 patients, 37.8% had hypogonadism based on the threshold 1 and 23.9% based on the threshold 2. Patients with hypogonadism, in both thresholds, had a higher chance of GS ≥ 7 (OR 1.79, p=0.02 and OR 2.08, p=0.012, respectively). In the multivariate analysis, adjusted for age, TT, body mass index (BMI) and race, low TT (p=0.023) and age (p=0.002) were found to be independent risk factors for GS ≥ 7. Among Black individuals, low serum TT was a stronger predictor of high-grade disease compared to White men (p=0.02). Conclusion: Hypogonadism is independently associated to higher GS in localized PCa. The effect of this association is significantly more pronounced among Black men and could partly explain aggressive characteristics of PCa found in this race.

Saved in:
Bibliographic Details
Main Authors: Albuquerque,George A. M. Lins de, Guglielmetti,Giuliano B., Barbosa,João Arthur B. A., Pontes Jr.,José, Fazoli,Arnaldo J. C., Cordeiro,Maurício D., Coelho,Rafael F., Carvalho,Paulo Afonso de, Gallucci,Fábio P., Padovani,Guilherme P., Park,Rubens, Cury,José, Nonemacher,Henrique, Srougi,Miguel, Nahas,William C.
Format: Digital revista
Language:English
Published: Associação Médica Brasileira 2017
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000800704
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0104-42302017000800704
record_format ojs
spelling oai:scielo:S0104-423020170008007042017-09-27Low serum testosterone is a predictor of high-grade disease in patients with prostate cancerAlbuquerque,George A. M. Lins deGuglielmetti,Giuliano B.Barbosa,João Arthur B. A.Pontes Jr.,JoséFazoli,Arnaldo J. C.Cordeiro,Maurício D.Coelho,Rafael F.Carvalho,Paulo Afonso deGallucci,Fábio P.Padovani,Guilherme P.Park,RubensCury,JoséNonemacher,HenriqueSrougi,MiguelNahas,William C. prostate cancer hypogonadism testosterone Summary Objective: To evaluate the relation between serum total testosterone (TT) and prostate cancer (PCa) grade and the effect of race and demographic characteristics on such association. Method: We analyzed 695 patients undergoing radical prostatectomy (RP), of whom 423 had serum TT collected. Patients were classified as having hypogonadism or eugonadism based on two thresholds of testosterone: threshold 1 (300 ng/dL) and threshold 2 (250 ng/dL). We evaluated the relation between TT levels and a Gleason score (GS) ≥ 7 in RP specimens. Outcomes were evaluated using univariate and multivariate analyses, accounting for race and other demographic predictors. Results: Out of 423 patients, 37.8% had hypogonadism based on the threshold 1 and 23.9% based on the threshold 2. Patients with hypogonadism, in both thresholds, had a higher chance of GS ≥ 7 (OR 1.79, p=0.02 and OR 2.08, p=0.012, respectively). In the multivariate analysis, adjusted for age, TT, body mass index (BMI) and race, low TT (p=0.023) and age (p=0.002) were found to be independent risk factors for GS ≥ 7. Among Black individuals, low serum TT was a stronger predictor of high-grade disease compared to White men (p=0.02). Conclusion: Hypogonadism is independently associated to higher GS in localized PCa. The effect of this association is significantly more pronounced among Black men and could partly explain aggressive characteristics of PCa found in this race.info:eu-repo/semantics/openAccessAssociação Médica BrasileiraRevista da Associação Médica Brasileira v.63 n.8 20172017-08-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000800704en10.1590/1806-9282.63.08.704
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Albuquerque,George A. M. Lins de
Guglielmetti,Giuliano B.
Barbosa,João Arthur B. A.
Pontes Jr.,José
Fazoli,Arnaldo J. C.
Cordeiro,Maurício D.
Coelho,Rafael F.
Carvalho,Paulo Afonso de
Gallucci,Fábio P.
Padovani,Guilherme P.
Park,Rubens
Cury,José
Nonemacher,Henrique
Srougi,Miguel
Nahas,William C.
spellingShingle Albuquerque,George A. M. Lins de
Guglielmetti,Giuliano B.
Barbosa,João Arthur B. A.
Pontes Jr.,José
Fazoli,Arnaldo J. C.
Cordeiro,Maurício D.
Coelho,Rafael F.
Carvalho,Paulo Afonso de
Gallucci,Fábio P.
Padovani,Guilherme P.
Park,Rubens
Cury,José
Nonemacher,Henrique
Srougi,Miguel
Nahas,William C.
Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
author_facet Albuquerque,George A. M. Lins de
Guglielmetti,Giuliano B.
Barbosa,João Arthur B. A.
Pontes Jr.,José
Fazoli,Arnaldo J. C.
Cordeiro,Maurício D.
Coelho,Rafael F.
Carvalho,Paulo Afonso de
Gallucci,Fábio P.
Padovani,Guilherme P.
Park,Rubens
Cury,José
Nonemacher,Henrique
Srougi,Miguel
Nahas,William C.
author_sort Albuquerque,George A. M. Lins de
title Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
title_short Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
title_full Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
title_fullStr Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
title_full_unstemmed Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
title_sort low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
description Summary Objective: To evaluate the relation between serum total testosterone (TT) and prostate cancer (PCa) grade and the effect of race and demographic characteristics on such association. Method: We analyzed 695 patients undergoing radical prostatectomy (RP), of whom 423 had serum TT collected. Patients were classified as having hypogonadism or eugonadism based on two thresholds of testosterone: threshold 1 (300 ng/dL) and threshold 2 (250 ng/dL). We evaluated the relation between TT levels and a Gleason score (GS) ≥ 7 in RP specimens. Outcomes were evaluated using univariate and multivariate analyses, accounting for race and other demographic predictors. Results: Out of 423 patients, 37.8% had hypogonadism based on the threshold 1 and 23.9% based on the threshold 2. Patients with hypogonadism, in both thresholds, had a higher chance of GS ≥ 7 (OR 1.79, p=0.02 and OR 2.08, p=0.012, respectively). In the multivariate analysis, adjusted for age, TT, body mass index (BMI) and race, low TT (p=0.023) and age (p=0.002) were found to be independent risk factors for GS ≥ 7. Among Black individuals, low serum TT was a stronger predictor of high-grade disease compared to White men (p=0.02). Conclusion: Hypogonadism is independently associated to higher GS in localized PCa. The effect of this association is significantly more pronounced among Black men and could partly explain aggressive characteristics of PCa found in this race.
publisher Associação Médica Brasileira
publishDate 2017
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000800704
work_keys_str_mv AT albuquerquegeorgeamlinsde lowserumtestosteroneisapredictorofhighgradediseaseinpatientswithprostatecancer
AT guglielmettigiulianob lowserumtestosteroneisapredictorofhighgradediseaseinpatientswithprostatecancer
AT barbosajoaoarthurba lowserumtestosteroneisapredictorofhighgradediseaseinpatientswithprostatecancer
AT pontesjrjose lowserumtestosteroneisapredictorofhighgradediseaseinpatientswithprostatecancer
AT fazoliarnaldojc lowserumtestosteroneisapredictorofhighgradediseaseinpatientswithprostatecancer
AT cordeiromauriciod lowserumtestosteroneisapredictorofhighgradediseaseinpatientswithprostatecancer
AT coelhorafaelf lowserumtestosteroneisapredictorofhighgradediseaseinpatientswithprostatecancer
AT carvalhopauloafonsode lowserumtestosteroneisapredictorofhighgradediseaseinpatientswithprostatecancer
AT galluccifabiop lowserumtestosteroneisapredictorofhighgradediseaseinpatientswithprostatecancer
AT padovaniguilhermep lowserumtestosteroneisapredictorofhighgradediseaseinpatientswithprostatecancer
AT parkrubens lowserumtestosteroneisapredictorofhighgradediseaseinpatientswithprostatecancer
AT curyjose lowserumtestosteroneisapredictorofhighgradediseaseinpatientswithprostatecancer
AT nonemacherhenrique lowserumtestosteroneisapredictorofhighgradediseaseinpatientswithprostatecancer
AT srougimiguel lowserumtestosteroneisapredictorofhighgradediseaseinpatientswithprostatecancer
AT nahaswilliamc lowserumtestosteroneisapredictorofhighgradediseaseinpatientswithprostatecancer
_version_ 1756409974640082944